Evidence map›Paper›PMID 39339338›Full record

ArticleMolecules (Basel, Switzerland)2024

Comprehensive Mapping of Cyclotides from

Liyan Yu, Hailiang Pan, Xiaohang Chen, Shan Gong, Qipeng Zhang, Yandong Zhang, Zhajun Zhan

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Scopoletin and Scoparone fromInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liyan YuKey Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, College of Pharmaceutical Science, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou 310014, China.
Hailiang PanZhejiang Peptides Biotech Co., Ltd., No. 8 Hengyizhi Road, Shengzhou, Shaoxing 312400, China.
Xiaohang ChenZhejiang Peptides Biotech Co., Ltd., No. 8 Hengyizhi Road, Shengzhou, Shaoxing 312400, China.
Shan GongZhejiang Peptides Biotech Co., Ltd., No. 8 Hengyizhi Road, Shengzhou, Shaoxing 312400, China.
Qipeng ZhangZhejiang Peptides Biotech Co., Ltd., No. 8 Hengyizhi Road, Shengzhou, Shaoxing 312400, China.
Yandong ZhangZhejiang Peptides Biotech Co., Ltd., No. 8 Hengyizhi Road, Shengzhou, Shaoxing 312400, China.
Zhajun ZhanKey Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, College of Pharmaceutical Science, Zhejiang University of Technology, No. 18 Chaowang Road, Gongshu District, Hangzhou 310014, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclotides are plant cyclic peptides with exceptional stability and diverse bioactivity, making them promising candidates for biomedical applications. Therefore, the study of cyclotides has attracted increasing attention in recent years. However, the existing cyclotide detection methods face limitations in sensitivity, accuracy, and reliability. To address these challenges, we developed an integrated strategy using a combination of strong cation exchange chromatography techniques for removing interfering small molecules, Orbitrap Exploris 480 mass spectrometry (OEMS); this is a detection and database searching-based method for cyclotide verification, which greatly improved the sensitivity, accuracy, and reliability of cyclotide identification. This strategy was subsequently employed for cyclotide mapping in

Indexed as

CyclotidesViolaAmino Acid SequenceMass SpectrometryPlant ProteinsTandem Mass SpectrometryCyclotidesPlant Proteinscyclic peptidescyclotidesOEMSViola philippica

Identifiers

PMID39339338
PMCPMC11434059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.